When looking at suspected rhabdomyosarcoma cases, what are peoples'
experiences or preferences between MyoD1 and myogenin?  We're considering
switching, but haven't done a thorough background check on the subject.  I
guess we're hoping you can help us with our homework!  Thank you!  Have an
enjoyable weekend and holiday(where appropriate, otherwise make up a holiday
to have on Monday to join the rest of us!).

Sally Ann Drew-MT(ASCP)
Univ. of Wis. Hospital and Clinics
IHC/ISH Clinical/Research Lab
Madison, WI 
(608)265-6596
(608)263-1568(fax)